SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-085185
Filing Date
2024-10-04
Accepted
2024-10-04 06:05:24
Documents
14
Period of Report
2024-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0216761-8k_nkgen.htm   iXBRL 8-K 31048
  Complete submission text file 0001213900-24-085185.txt   251193

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nkgn-20241003.xsd EX-101.SCH 3882
3 XBRL DEFINITION FILE nkgn-20241003_def.xml EX-101.DEF 26779
4 XBRL LABEL FILE nkgn-20241003_lab.xml EX-101.LAB 37008
5 XBRL PRESENTATION FILE nkgn-20241003_pre.xml EX-101.PRE 25403
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0216761-8k_nkgen_htm.xml XML 6002
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40427 | Film No.: 241353414
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)